Open data in drug discovery and development: lessons from malaria

• Published in: Nature reviews. Drug discovery Vol. 15; no. 10; pp. 661 - 662
• Main Authors: Wells, Timothy N. C., Willis, Paul, Burrows, Jeremy N., van Huijsduijnen, Rob Hooft
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01-10-2016; Nature Publishing Group
• Subjects: 631/154; 692/699/255/1629; Animals; Antimalarials - chemistry; Antimalarials - therapeutic use; Biomedical and Life Sciences; Biomedicine; Biotechnology; Cancer Research; comment; Drug Discovery - trends; Drug evaluation; Drug therapy; Humans; Malaria; Malaria - diagnosis; Malaria - drug therapy; Medicinal Chemistry; Methods; Molecular Medicine; Pharmacology/Toxicology; Statistics as Topic - methods; Statistics as Topic - trends; Switzerland
• ISSN: 1474-1776; 1474-1784
• DOI: 10.1038/nrd.2016.154

There is a growing consensus that drug discovery thrives in an open environment. Here, we describe how the malaria community has embraced four levels of open data — open science, open innovation, open access and open source — to catalyse the development of new medicines, and consider principles that could enable open data approaches to be applied to other disease areas.
There is a growing consensus that drug discovery thrives in an open environment. Here, we describe how the malaria community has embraced four levels of open data — open science, open innovation, open access and open source — to catalyse the development of new medicines, and consider principles that could enable open data approaches to be applied to other disease areas.